Related Experiment Video
Updated: Aug 12, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
Post-COVID Multisystem Inflammatory Syndrome-Adult (MIS-A) Presenting with Rhabdomyolysis and AKI
Mastakim Ahmed Mazumder1, Ajit Singh Narula2, Sanjeev Gulati2
1Consultant Nephrology and Kidney Transplant, Kidney and Urology Institute, Fortis Escorts, Okhla, New Delhi, India.
Abstract:
Multisystem inflammatory syndrome is a rarely reported post-COVID (coronavirus disease) phenomenon in adults. Our understanding of the multisystem inflammatory syndrome- adult (MIS-A) is based on multiple case reports that have demonstrated heterogeneous clinical presentations and treatment options. Rhabdomyolysis is an unusual presentation of MIS-A. We report the case of a 61-year-old man who presented with rhabdomyolysis with acute kidney injury (AKI), acute inflammatory demyelinating polyneuropathy (AIDP), myocarditis, disseminated intravascular coagulation, and minimal respiratory symptoms. The patient was found to have post-COVID inflammatory syndrome and recovered with supportive treatment and intravenous immunoglobulin (2 g/kg over 5 days). COVID-19 (coronavirus disease 2019) antibody positivity played a significant role in making the diagnosis of MIS-A and in providing prompt treatment.
Insights
Multisystem inflammatory syndrome in adults (MIS-A) is a rare post-COVID condition. This case highlights rhabdomyolysis as an unusual MIS-A presentation, emphasizing prompt diagnosis and treatment for recovery.
Area of Science:
- Internal Medicine
- Infectious Diseases
- Neurology
Background:
- Multisystem inflammatory syndrome in adults (MIS-A) is a rare post-coronavirus disease (COVID-19) complication.
- Clinical presentations and treatment strategies for MIS-A are diverse, primarily documented through case reports.
- Rhabdomyolysis is an uncommon manifestation of MIS-A.
Observation:
- A 61-year-old male presented with rhabdomyolysis and acute kidney injury (AKI).
- Additional symptoms included acute inflammatory demyelinating polyneuropathy (AIDP), myocarditis, and disseminated intravascular coagulation.
- The patient exhibited minimal respiratory symptoms, suggesting a non-typical COVID-19 presentation.
Findings:
- The patient was diagnosed with post-COVID inflammatory syndrome (MIS-A).
- Diagnosis was supported by positive COVID-19 antibody testing.
- Treatment involved supportive care and intravenous immunoglobulin (2 g/kg over 5 days).
Implications:
- This case expands the understanding of MIS-A presentations, including severe rhabdomyolysis.
- Early diagnosis of MIS-A, aided by serological testing, is crucial for timely intervention.
- Effective management can lead to favorable outcomes in patients with complex MIS-A manifestations.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome I : Introduction
Acute Kidney Injury V: Interprofessional Care

